Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
2.930
+0.010 (0.34%)
At close: Mar 28, 2025, 4:00 PM
2.990
+0.060 (2.05%)
After-hours: Mar 28, 2025, 6:32 PM EDT
Rezolute Employees
Rezolute had 59 employees as of June 30, 2024. The number of employees increased by 8 or 15.69% compared to the previous year.
Employees
59
Change (1Y)
8
Growth (1Y)
15.69%
Revenue / Employee
n/a
Profits / Employee
-$1,205,661
Market Cap
177.37M
Employees Chart
RZLT News
- 4 days ago - Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Rezolute: Late-Stage Study Targeting Hyperinsulinism - Seeking Alpha
- 6 weeks ago - Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism - GlobeNewsWire
- 2 months ago - Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 4 months ago - Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Rezolute: Ersodetug Downstream Tech Could Ignite The Hyperinsulinism Market - Seeking Alpha
- 6 months ago - Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update - GlobeNewsWire